Skip to content

Study on the Neuroprotective Benefits of an Ayurvedic Treatment in Patients with Primary Open-Angle Glaucoma (Kaphaja Adhimantha)

A randomized clinical trial to evaluate the neuroprotective effect of Ayurveda treatment protocol (AY/SHA/NIA/POAG/2024)as an adjuvant therapy in Kaphaja Adhimantha with special reference to primary open angle glaucoma - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/102009
Enrollment
40
Registered
2026-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H401- Open-angle glaucoma

Interventions

None listed

Sponsors

National Institute of Ayurveda Jaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria 1.All patients with primary open angle glaucoma who exhibit the signs and symptoms of Kaphaja Adhimantha, including Shopha, Srava and Shirahshula, Rupam Pashyati Dukhen 2.Patients aged between 30-70 years. 3.Best corrected visual acuity (BCVA) more than 6/60. 4.Patients with IOP in range between 22-30 mm of Hg.

Exclusion criteria

Exclusion criteria: Exclusion criteria 1.Other types of glaucoma, including inflammatory, trauma-induced, exfoliative, pigmentary, and closed-angle glaucoma, as well as developmental glaucoma. 2.Glaucoma with hazy media that interferes with fundus examination and visual field mapping. 3.POAG with advanced stage of Optic atrophy with blindness. 4.Patients who have undergone Glaucoma surgery. 5.Patients who have undergone any ocular surgical intervention within 3 months. 6.Patients with any systemic illness which may affect the drug in clinical study

Design outcomes

Primary

MeasureTime frame
Changes in pattern deviation in RNFL thickness through OCTTimepoint: From baseline to day 61

Secondary

MeasureTime frame
Changes in Visual acuity and sign and symptoms of Kaphaja Adhimantha with special reference to Primary Open Angle GlaucomaTimepoint: From baseline to day 61

Countries

India

Contacts

Public ContactDr Kalpana Chhaniwal

National Institute of Ayurveda Jaipur

Shamsa_fiaz@yahoo.com8764009846

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026